This presentation contains forward-looking statements, including but not limited to, projections of financial developments, market activities, future performance of products and solutions or planned transactions, containing risks and uncertainties. These forward- looking statements are subject to change based on known or unknown risks and various other factors, which could cause the actual results, performance or events to differ materially from the statements made herein.
This presentation is not an offer to sell or a solicitation of offers to purchase or subscribe for shares of Sulzer or medmix and is not a prospectus in the sense of art. 35 of the Swiss Financial Services Act.
Any offering of securities mentioned herein will not be registered under the United States Securities Act of 1933, as amended (the "Act"), and such securities may not be offered or sold in the United States of America absent registration or an applicable exemption from registration requirements under the Act.
Notice to shareholders in the United Kingdom
The communication of this presentation and any other documents or materials relating to this presentation are not being made, and such documents and/or materials have not been approved by, an authorised person for the purposes of section 21 of the Financial Services and Markets Act 2000. Accordingly, this presentation and such documents and/or materials are not being distributed to, and must not be passed on to, persons in the United Kingdom ("UK") other than (i) persons falling within Article 43(2) of the Financial Services and Markets Act (Financial Promotion) Order 2005 (as amended, the "Order"), including existing creditors and members of Sulzer, or (ii) persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) may otherwise lawfully be communicated or caused to be communicated (all such persons described in (i) and (ii) above together being referred to as "Relevant Persons". In the UK, any investment or investment activity to which this presentation or any related documents and/or materials relate is available only to Relevant Persons and will be engaged in only with Relevant Persons. Any person in the UK who is not a Relevant Person should not act or rely on this presentation or any related documents and/or materials or any of its or their contents.
Note on Alternative Performance Measures (APM): all bridges from APM to reported figures can be found in the financial section of Sulzer's reports.
Rotating Equipment Services
Financials and Targets
G. Poux-Guillaume - CMD Introduction
Greg Poux-Guillaume - CEO
Sulzer (pro-forma post spin-off)
Pure play flow control company with attractive technology portfolio in growth markets driven by sustainability
Pumps Equipment Standard to highly engineered pumps and other specialized equipment, for water, industry and energy
Rotating Equipment Services Parts, service and refurbishment for pumps, turbines, compressors, motors & drives, etc.
Separation technology for chemicals and refining, with a strong position in emerging biopolymers and recycling
order intake 2020 (CHF)
Operational Profitability 2020
G. Poux-Guillaume - Overview
This is an excerpt of the original content. To continue reading it, access the original document here.